Skip to main content
drug protocol number
TMC435HPC3014
drug sponsor
Janssen-Cilag International NV
drug study
TMC435 (simeprevir) / Pegylated interferon alfa-2a (PegIFNα-2a) / Ribavirin (RBV)
drug trial site
King Faisal Specialist Hospital and Research Center (Riyadh)_ King Abdulaziz Medical City NG (Riyadh)_ King Khalid University Hospital (Riyadh)
drug status
Completed
drug phase